Edwards Lifesciences Corp. is a healthcare company based in the United States that specializes in designing, manufacturing, and marketing medical devices for advanced stages of structural heart disease. Since its spin-off from Baxter International in 2000, Edwards Lifesciences has become a leader in the industry, particularly in ESG-friendly products like surgical tissue heart valves and transcatheter valve technologies. With a medium-risk rating score of 22.1, the company derives a significant portion of its sales from international markets.